Prevalence of multidrug resistant micro-organism carriage in patients undergoing an ERCP in four different countries

Prevalence of multidrug resistant micro-organism carriage in patients undergoing an ERCP in four different countries - The PREVENT study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50359

Enrollment

343

Registered

2021-12-14

Start date

2022-01-31

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duodenoscope associated infections

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The subject is planned to undergo an ERCP procedure, either through an outpatient department or an inpatient department - The subject is >= 18 years old - The subject is capable to understand the information required to give informed consent

Exclusion criteria

Exclusion criteria: - In case the inclusion criteria were not met

Design outcomes

Primary

Measure	Time frame
The prevalence of MDRO's in patients undergoing ERCP in four different countries: Italy, the Netherlands, United States and India.	—

Secondary

Measure	Time frame
- To identify risk factors that predict MDRO carriage. - Prevalence of contamination of duodenoscopes in a Dutch tertiary care setting. - If the presence of MDRO in the rectal and nasal/throat E-swabs predicts the presence of MDRO in the duodenum. - What is the composition of the duodenal microbiome of patients undergoing an ERCP. - What is the composition of the rectal microbiome of patients undergoing an ERCP - What is the incidence of duodenoscope-associated colonization and infection in patients who have been treated with a colonized duodenoscope.	—

Measure

Time frame

- To identify risk factors that predict MDRO carriage. - Prevalence of contamination of duodenoscopes in a Dutch tertiary care setting. - If the presence of MDRO in the rectal and nasal/throat E-swabs predicts the presence of MDRO in the duodenum. - What is the composition of the duodenal microbiome of patients undergoing an ERCP. - What is the composition of the rectal microbiome of patients undergoing an ERCP - What is the incidence of duodenoscope-associated colonization and infection in patients who have been treated with a colonized duodenoscope.

—

Countries

Netherlands

Outcome results